CME/CE
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
3:45
Faculty: Virginia Kaklamani, MD, DSc
Hear an expert discussion between Dr. Komal Jhaveri and Dr. Virginia Kaklamani as they examine the evolving role of oral selective estrogen receptor degraders (SERDs), including PROTACs and novel combination strategies, in the treatment of ER+/HER2− metastatic breast cancer. Drs. Jhaveri and Kaklamani review emerging efficacy and safety data, considerations…